Schering-Plough Corp. has reported that its new AIDS drug vicriviroc was able to block the AIDS virus more effectively than a combination of older medicines alone. About 56% of patients given 30-mg vicriviroc combined with older treatments saw the virus reduced to imperceptible levels, compared with 14% who took only the older medications, a company-sponsored study showed.

Related Summaries